| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.39 | 0.007 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.37 | 0.04 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.35 | 0.3 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.28 | 0.04 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.08 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |